Literature DB >> 10492654

Follow up of workers previously exposed to silver solder containing cadmium.

H J Mason1, N Williams, S Armitage, M Morgan, S Green, B Perrin, W D Morgan.   

Abstract

OBJECTIVES: To study longitudinal biological monitoring data on urinary and blood cadmium collected in a small cohort of nine workers who had been brazing for several years with solders containing cadmium.
METHODS: Cadmium was measured by neutron activation analysis in livers and kidneys, and estimates of renal function were carried out in 1983 and 1995. During the intervening period exposure to cadmium was dramatically reduced by local exhaust ventilation control and substitution of the solder containing cadmium.
RESULTS: From urinary protein measurements there was evidence within the group of increasing renal tubular damage over the 12 year period, even though exposure to cadmium was dramatically reduced over this period and almost eliminated by 1995. There was no evidence from serum creatinine of decreasing glomerular filtration rate, and the renal tubular handling of calcium, phosphate, or urate had not worsened significantly. Blood and urinary cadmium concentrations reduced significantly over the 12 year period but were still substantial in 1995. Blood cadmium concentrations tended to reflect cadmium body burden in 1995 when exposure had been low for several years, and decreased most significantly during 1983-90. By contrast urinary cadmium concentrations only decreased significantly from about 1990 onwards. Urinary cadmium was not significantly correlated with liver or kidney cadmium concentration in either 1983 or 1995. This may be due to the level of tubular dysfunction in the cohort. Calculated cumulative excretion of cadmium over the 12 year period was substantially greater than the loss of cadmium measured in livers and kidneys and the derived loss in body burden. Reasons for this are discussed. It is possible that in cohorts, where renal damage is apparent, urinary concentrations reflect a substantial component of current exposure rather than stored body losses.
CONCLUSIONS: The data reinforce the concept that blood cadmium concentrations may not always reflect recent exposure, but may reflect body burden derived from historical exposure depending on the degree of current exposure; and that the decline in urinary and blood cadmium measurements after removal from, or reduction in, exposure will be slow and depend on the historical body burden.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10492654      PMCID: PMC1757775          DOI: 10.1136/oem.56.8.553

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  9 in total

1.  Longitudinal studies of exposure to cadmium.

Authors:  R Armstrong; D R Chettle; M C Scott; M Blindt; H J Mason
Journal:  Br J Ind Med       Date:  1992-08

Review 2.  Manufacturing process, resultant risk profiles and their control in the production of nickel-cadmium (alkaline) batteries.

Authors:  R G Adams
Journal:  Occup Med (Lond)       Date:  1992-05       Impact factor: 1.611

3.  beta 2-Microglobulinuria among workers previously exposed to cadmium: follow-up and dose-response analyses.

Authors:  C G Elinder; C Edling; E Lindberg; B Kågedal; O Vesterberg
Journal:  Am J Ind Med       Date:  1985       Impact factor: 2.214

4.  Follow-up of biologic monitoring results in cadmium workers removed from exposure.

Authors:  M A McDiarmid; C S Freeman; E A Grossman; J Martonik
Journal:  Am J Ind Med       Date:  1997-09       Impact factor: 2.214

5.  Biological half-time of cadmium in the blood of workers after cessation of exposure.

Authors:  L Järup; A Rogenfelt; C G Elinder; K Nogawa; T Kjellström
Journal:  Scand J Work Environ Health       Date:  1983-08       Impact factor: 5.024

6.  Blood cadmium as an indicator of dose in a long-term follow-up of workers previously exposed to cadmium.

Authors:  L Järup; B Persson; C G Elinder
Journal:  Scand J Work Environ Health       Date:  1997-02       Impact factor: 5.024

7.  Measurement of urinary retinol-binding protein by enzyme-linked immunosorbent assay, and its application to detection of tubular proteinuria.

Authors:  M D Topping; H W Forster; C Dolman; C M Luczynska; A M Bernard
Journal:  Clin Chem       Date:  1986-10       Impact factor: 8.327

8.  Occupational cadmium exposure in jig solderers.

Authors:  N J Smith; M D Topping; J D Stewart; J G Fletcher
Journal:  Br J Ind Med       Date:  1986-10

9.  Reversibility of microproteinuria in cadmium workers with incipient tubular dysfunction after reduction of exposure.

Authors:  H A Roels; F J Van Assche; M Oversteyns; M De Groof; R R Lauwerys; D Lison
Journal:  Am J Ind Med       Date:  1997-05       Impact factor: 2.214

  9 in total
  6 in total

1.  Cadmium exposure and cancer mortality in the Third National Health and Nutrition Examination Survey cohort.

Authors:  Scott V Adams; Michael N Passarelli; Polly A Newcomb
Journal:  Occup Environ Med       Date:  2011-11-07       Impact factor: 4.402

2.  Cadmium blood and urine concentrations as measures of exposure: NHANES 1999-2010.

Authors:  Scott V Adams; Polly A Newcomb
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-09-04       Impact factor: 5.563

3.  Urinary Cadmium and Risk of Invasive Breast Cancer in the Women's Health Initiative.

Authors:  Scott V Adams; Martin M Shafer; Matthew R Bonner; Andrea Z LaCroix; JoAnn E Manson; Jaymie R Meliker; Marian L Neuhouser; Polly A Newcomb
Journal:  Am J Epidemiol       Date:  2016-03-31       Impact factor: 4.897

4.  Is Male Rheumatoid Arthritis an Occupational Disease? A Review.

Authors:  Dan Murphy; David Hutchinson
Journal:  Open Rheumatol J       Date:  2017-07-27

Review 5.  Environmental toxin-induced acute kidney injury.

Authors:  Benjamin A Vervaet; Patrick C D'Haese; Anja Verhulst
Journal:  Clin Kidney J       Date:  2017-07-28

6.  Cadmium and lead in blood in relation to low bone mineral density and tubular proteinuria.

Authors:  Tobias Alfvén; Lars Järup; Carl-Gustaf Elinder
Journal:  Environ Health Perspect       Date:  2002-07       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.